Trademark: TRUVADA EMTRICITABINE 200 MG / TENOFOVIR DISOPROXIL FUMARATE 300 MG, TABLETS FOR PREP PRE-EXPOSURE PROPHYLAXIS 1853588
Word
TRUVADA EMTRICITABINE 200 MG / TENOFOVIR DISOPROXIL FUMARATE 300 MG, TABLETS FOR PREP PRE-EXPOSURE PROPHYLAXIS
Device Descrption:
DIAMOND,DIVIDED
ID
1853588
Trademark Type
Figurative
Status
Protected: Registered/protected
Application Date
20 April 2017
Registration Date
20 April 2017
Renewal Date
20 April 2027
Owner(s)
Gilead Sciences, Inc.
Service
Refer to WIPO address for Correspondence
Goods and Services:
Class 44:
Medical services, namely, providing information regarding the prevention of HIV infection

Trademark Alertz ® - GRJR PTY LTD 2024 - Privacy Policy - Terms of Use

The information provided on Trademark Alertz is not legal or professional advice. Information may have been obtained from third parties and may contain errors. You must make your own enquiries and seek independent advice from relevant industry professionals before acting or relying on any information from Trademark Alertz. All trade mark information has been obtained from and made publicly available by IP Australia. Copyright of the trademark data resides with IP Australia. ipaustralia.gov.au